Systematic Study of Tissue Factor Expression in Solid tumors (vol 6, e1699, 2023)

被引：0
|
作者：
de Bono, J. S.
Harris, J. R.
Burm, S. M.
Vanderstichele, A.
Houtkamp, M. A.
Aarass, S.
Riisnaes, R.
Figueiredo, I
Rodrigues, D. Nava
Christova, R.
Olbrecht, S.
Niessen, H. W. M.
Ruuls, S. R.
Schuurhuis, D. H.
van Bueren, J. J. Lammerts
Breij, E. C. W.
Vergote, I
机构：
来源：
CANCER REPORTS | 2024年 / 7卷 / 07期
关键词：
D O I：
10.1002/cnr2.2143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] "Accuracy of predictive equations versus indirect calorimetry for the evaluation of energy expenditure in cancer patients with solid tumors" "An integrative systematic review study" (vol 35, pg 12, 2020)
    不详
    CLINICAL NUTRITION ESPEN, 2021, 42 : 418 - 418
  • [42] Accuracy of predictive equations versus indirect calorimetry for the evaluation of energy expenditure in cancer patients with solid tumors "An integrative systematic review study (vol 35, pg 12, 2020)
    Mazzo, Rafaela
    Ribeiro, Francieli Barreiro
    Junqueira Vasques, Ana Carolina
    CLINICAL NUTRITION ESPEN, 2021, 42 : 416 - 416
  • [43] Expression of Interleukin 6 and Tumor Necrosis Factor Alpha in Soft Tissue over Ceramic and Metal Implant Materials Before Uncovering: A Clinical Pilot Study
    Nickenig, Hans-Joachim
    Schlegel, Karl Andreas
    Wichmann, Manfred
    Eitner, Stephan
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2012, 27 (03) : 671 - 676
  • [44] Clinical study of pituitary tumors with EEA resection and its influence on the expression of tumor necrosis factor-α, interleukin-6, and interleukin-12 in patients
    Wang, Wentao
    Zhong, Dequan
    Cheng, Hua
    Ji, Chengfu
    Shen, Zhouming
    Mao, Yangming
    EUROPEAN JOURNAL OF INFLAMMATION, 2019, 17
  • [45] Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas (vol 26, pg 272, 2023)
    Streeter, Samuel S.
    Xu, Xiaochun
    Hebert, Kendra A.
    Werth, Paul M.
    Hoopes, P. Jack
    Jarvis, Lesley A.
    Pogue, Brian W.
    Paulsen, Keith D.
    Samkoe, Kimberley S.
    Henderson, Eric R.
    MOLECULAR IMAGING AND BIOLOGY, 2025,
  • [46] Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study (vol 8, e000437, 2020)
    Shen, L.
    Guo, J.
    Zhang, Q.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [47] Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study (vol 10, e004223, 2022)
    Naing, A.
    Powderly, J. D.
    Nemunaitis, J. J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [48] The burden and trend of diseases and their risk factors in Australia, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 (vol 8, pg e585, 2023)
    不详
    LANCET PUBLIC HEALTH, 2023, 8 (09): : E669 - E669
  • [49] A phase I study evaluating DLYE5953A, an antibody-drug conjugate targeting the tumor-associated antigen lymphocyte antigen 6 complex locus E (Ly6E), in patients (Pts) with solid tumors
    Modi, S.
    Eder, J. P.
    Lorusso, P.
    Weekes, C.
    Chandarlapaty, S.
    Tolaney, S. M.
    McLaughlin, J.
    Camidge, D. R.
    Chang, C-W.
    Nazzal, D.
    Chen, S-C.
    Schuth, E.
    Brunstein, F.
    Darbonne, W.
    Flanagan, W.
    Ungewickell, A.
    Shapiro, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1 (vol 97, e00815-23, 2023)
    Mori, Seiichiro
    Ishii, Yoshiyuki
    Takeuchi, Takamasa
    Kukimoto, Iwao
    JOURNAL OF VIROLOGY, 2023, 97 (11)
12345